✦ LIBER ✦

A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma

✍ Scribed by Weaver, C H; Greco, F A; Hainsworth, J D; Zhen, B; Baldwin, P; Wittlin, F; Lewis, M; West, W H; Schwartzberg, L; Buckner, C D

Book ID: 110010301
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 89 KB
Volume: 20
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1700976

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose mitoxantrone and cyclophospham

High-dose mitoxantrone and cyclophosphamide without stem cell support in patients with high-risk and advanced breast carcinoma : A Phase II multicentric trial

✍ Jose Luis Pérez-Gracia; Ramon Colomer; Emilio Esteban; Ramón Barceló; Manuel Ben 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

Phase I–II evaluation of rapid sequence

Phase I–II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma

✍ Weaver, C H; Zhen, B; Schwartzberg, L S; Leff, R; Magee, M; Geier, L; Deaton, K; 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 61 KB

Phase I/II trial of multicycle high-dose

Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer

✍ Frickhofen, N; Berdel, W E; Opri, F; Haas, R; Schneeweiss, A; Sandherr, M; Kuhn, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Sequential cycles of high-dose chemother

Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer

✍ Wandt, H; Birkmann, J; Denzel, Th; Schäfer, K; Schwab, G; Pilz, D; Egger, H; Bot 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB

A phase I/II study of sequential, dose-e

A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas

✍ Carsten Bokemeyer; Anke Franzke; Jörg T. Hartmann; Christoph Schöber; Lubomir Ar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

ide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in

A phase I dose escalation study of high-

A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

✍ Demirer, T; lhan, O; Mandel, N M; Arat, M; Günel, N; Çelebi, H; Üstün, C; Akan, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB